Osanni Bio
Provider of a development-stage therapeutics platform.
Healthcare
📍 San Francisco, CA
Current Valuation
Private
PRIVATE
Provider of a development-stage therapeutics platform. Headquartered in San Francisco, CA. Raised $190M in Series B funding in June 2026 led by Patient Square Capital.
Company Profile
Last Round
Series B — $190M (Jun 2026) · Lead: Patient Square Capital
Fundraising Status
Series B · $190M · this month
privateTotal raised $190M1 disclosed rounds
Funding History
| Round | Amount | Date | Lead Investor | Post-Money |
|---|
| Series B | $190M | Jun 2026 | Patient Square Capital | — |
Investors
Patient Square Capital · Horowitz Group · Invus Opportunities · Retinal Degeneration Fund
HealthcareBiotechnologyRecently Funded
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of recent date. Refreshed quarterly.